Shareholders information/ other details
SHAREHOLDERS INFORMATION / OTHER DETAILS
Intimation for Closure of Trading Window for the quarter ended December 31, 2023.
Certificate Under regulation 74(5) of SEBI LODR Regulations, 2015
Corporate Governance Report for the quarter ended 30th September, 2023
Certificate Under regulation 76 of SEBI LODR Regulations, 2015
Intimation for Closure of Trading Window for the quarter ended September 30, 2023
Voting Results of 50th AGM
Form MGT - 7
Independent Directors Familarisation Programme 2022-23
Intimation for Closure of Trading Window for the year ended March 31, 2023
Notice of Postal Ballot
Newspaper Advertisement under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
Outcome of Board Meeting 13.02.2023
Authorised Key Managerial Personnel under Regulation 30(5)
Criteria for making payment to Non- Executive Director
Intimation of Board Meeting 13.02.2023
Intimation for Closure of Trading Window for the quarter ended December 31, 2022
Outcome of Board Meeting 11.11.2022
Intimation of Board Meeting 11.11.2022
Intimation for Closure of Trading Window for the quarter ended September 30, 2022
Independent Directors Familarisation Programme 2021-22
Form MGT-7
Outcome of Board meeting 05.08.2022
Intimation of Board Meeting 05.08.2022
Intimation of Closure Trading Windows
Postal Ballot
Out Come of Board Meeting 04.02.2022
Declaration with respect to Non - Applicability of Large Corporate Framework
Composition of Committee
Out Come of Board Meeting 26.05.2022
Intimation Board Meeting
Intimation of Result of postal Ballot and Scrutinizers Report
Intimation SAT Order
Intimation of Board Meeting 04.02.2022
Newspaper Advertisement under Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015
Intimation regarding closure of Trading Window
Compliance Certificate - Regulation 7 (3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Outcome of Board Meeting dated 12th November, 2021.
Notice of Board Meeting to be held on 12.11.2021
Intimation for Closure of Trading Window for the quarter ended September 30, 2021
Intimation under Regulation 30
Voting Results of 48th AGM
Notice of 48th AGM
Intimation under Regulation 30 TTA
Outcome of Board Meeting dated 12th August, 2021
Intimation pursuant to Regulation 30 read with Schedule III of SEBI (LODR) Regulations, 2015
Notice of Board Meeting to be held on 12.08.2021
Outcome of Board Meeting dated 05th July, 2021
Outcome of Board Meeting dated 06th July, 2021
Intimation for Closure of Trading Window for the quarter ended June 30, 2021
Update on Setting-up of new intermediate manufacturing facility
Disclosure of RPT for the year ended March 31, 2021
Intimation regarding receipt of Resignation from Statutory Auditors
Notice of Board Meeting to be held on 20.05.2021
Intimation for Closure of Trading Window for the year ended March 31, 2021
Outcome of Board Meeting dated 21th March, 2021
Notice of 47th AGM
Newspaper Advertisement for attention of shareholders
Outcome of Board Meeting dated 10th August, 2020
Notice of Board Meeting to be held on 10.08.2020
Disclosure of RPT for the year ended March 31, 2020
Intimation for Closure of Trading Window for the quarter ended June 30, 2020
Outcome of Board Meeting dated 29th June, 2020
Notice of Board Meeting to be held on 29.06.2020
Update on Development of Favipiravir
Update on Certificate of Suitability (CEP) for Hydroxychloroquine Sulphate (HCQS)
Intimation for Closure of Trading Window for the quarter ended December 31, 2019
Notice of Board Meeting to be held on 24.01.2020
Update on Active Pharmaceutical Ingredients (APIs)
Intimation for Closure of Trading Window for the quarter ended March 31, 2020
Outcome of Board Meeting dated 24th January, 2020
Outcome of Board Meeting dated 2nd November 2019
Disclosure of RPT for the half year ended September 30 ,2019
Outcome of Board Meeting dated 2nd November, 2019
Notice of Board Meeting dated 02.11.2019
Intimation for Closure of Trading Window for the quarter ended September 30, 2019
Voting Results of 46th AGM
Disclosure of RPT for the FY ended 31st March ,2019
Intimation for closure of Trading Window for the quarter ended 30th June, 2019
Notice of 46th AGM
Attendance Slip of 46th AGM
Proxy Form of 46th AGM
Outcome of Board Meeting dated 26th July, 2019
Announcement under Regulation 30 (LODR)-Change in Directorate
Authorised Key Managerial Personnel under Regulation 30(5)
Notice of Board Meeting dated 26.07.2019
Outcome of Board Meeting dated 08th july, 2019
Outcome of Board Meeting dated 09.05.2019
Notice of Board Meeting dated 09.05.2019
Outcome of Board Meeting dated 11.02.2019
Notice of Board Meeting dated 11.02.2019
Outcome of Board Meeting dated 14.11.2018
Notice of Board Meeting dated 14.11.2018
Disclosure of Voting Results of 45th AGM of members of the Company held on 25.09.2018
Notice of 45th AGM
Proxy AGM 45th
Attendance Slip 45th AGM
Outcome of Board Meeting dated 14.08.2018
Reg 30 Updates Changes in Directorate
Notice of Board Meeting dated 14.08.2018
Notice of Board Meeting dated 28.05.2018
Outcome of Board Meeting dated 12.02.2018
Revised Outcome of Board Meeting dated 12.12.2017
Outcome of Board Meeting dated 12.12.2017
Outcome of Board Meeting dated 20.11.2017
Outcome of Board Meeting dated 11.08.2017
Outcome of Board Meeting dated 08.05.2017
Notice of Board Meeting dated 12.02.2018
Regulation 30 - Updates Change in Directors
Notice of Board Meeting dated 20.11.2017
Disclosure of Voting Results of 44th AGM of members of the Company held on 26.09.2017
Notice of Postponement of Board Meeting dated 04.08.2017
Notice of Board Meeting dated 04.08.2017
Authorized KMP
Regulation 30- Updates WHO Geneva Approval for Unit 2
Notice of Board Meeting dated 08.05.2017
Regulation 30- Updates WHO Geneva inspection at Unit 2
Notice of Board Meeting dated 06.02.2017
Regulation 30 Credit Rating Updates
Notice of Board Meeting dated 10.11.2016
Disclosure of Voting Results of 43rd AGM of members of the Company held on 30.09.2016
Proceedings of 43rd AGM
Notice of Board Meeting dated 01.08.2016
Notice of Postponement of Board Meeting dated 06.06.2016
Investor Presentation
Resignation Letter of Ms. Meenal Sukhani
Intimation under Regulation 30 of SEBI for change in directorship
Notice of Board Meeting dated 16.05.2016
Mangalam Drugs Organics Investor Presentation - Jan 2016
Rating Letter (Basel II)
Notice of Board Meeting 2016
Scrutinizers Report 2015
Scrutinizer Report for AGM held on 29th September 2014
Certificate Under regulation 74(5) of SEBI LODR Regulations, 2015
Corporate Governance Report for the quarter ended 30th June, 2022
Certificate under regulation 13(3) of SEBI LODR Regulations, 2015
Certificate under regulation 76 of SEBI LODR Regulations, 2015
Details of Nodal Officer – IEPF
Shri Govardhan M. Dhoot — Chairman & Managing Director
Company Name: Mangalam Drugs & Organics Ltd.
CIN: L24230MH1972PLC116413
Registered Office:
Rupam Building, 3rd Floor, 239, P D’ Mello Road (Near GPO),
Mumbai – 400 001, Maharashtra, INDIA.
Tel: +91 – 22 – 2261 6200 / 6300
Email ID: cs@mangalamdrugs.com
Unclaimed Dividend 2017-18 Interim Dividend
Secretarial Department
Mr. Jayant Barde – Company Secretary & Compliance Officer
Mangalam Drugs & Organics Ltd.
Rupam Building, 3rd Floor,
239, P D’ Mello Road (Near GPO),
Mumbai – 400 001. Maharashtra, INDIA.
Tel: +91 – 22 – 2261 6200 / 6300
Email ID: cs@mangalamdrugs.com
R & T Agent
Link Intime India Pvt. Ltd.
C-101, 247 Park, L.B.S Marg,
Vikhroli (West), Mumbai-400083.
Tel No.: 91-22-49182670
Fax: 91 22 49186060
Email ID: cs@mangalamdrugs.com
Grievance redressal and other relevant details:
Mr. Jayant Barde – Company Secretary & Compliance Officer
Mangalam Drugs & Organics Ltd.
Rupam Building, 3rd Floor,
239, P D’ Mello Road (Near GPO),
Mumbai – 400 001. Maharashtra, INDIA.
Tel: +91–22–2261 6200/6300
Email ID: cs@mangalamdrugs.com
